The 81st Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 1-9A Malignant Lymphoma: Diagnosis/Comorbidity/Others

Fri. Oct 11, 2019 9:00 AM - 10:00 AM No.9 (Tokyo International Forum, 4F G402)

Chair: Shigeru Kusumoto (Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences)

Akihiro Tomita1, Takahiko Yasuda2, Masashi Sanada2, Hiroaki Miyoshi3, Koichi Ohshima3, Kennosuke Karube4, Momoko Nishikori5, Hiroki Kurahashi6, Chisako Iriyama1, Akinao Okamoto1, Junji Hiraga7, Shigeru Kusumoto8, Noriko Fukuhara9, Matsuo Yamamoto2, Akiko Saito2, Hirokazu Nagai2, Masataka Okamoto1, Hiroyoshi Hattori2, Takashi Kanamori2,8, Dai Nishijima2, Yuichi Shiraishi10, Satoru Miyano11, Seishi Ogawa12, Keizo Horibe2 (1.Dept. Hematol., Fujita Health Univ., Toyoake, Japan, 2.Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, 3.Dept. Pathol., Kurume Univ. Sch. Med., Kurume, 4.Dept. Pathol. Cell Biol., Grad. Med., University of the Ryukyus, 5.Dept. Hematol Oncol, Kyoto Univ. Grad. Med., Kyoto, 6.Div. Mol. Genet., Inst. Comprehensive Med. Sci., Fujita Health Univ, 7.Dept. Hematol, Toyota Kosei Hospital, Toyota, 8.Dept Hematol Oncol, Nagoya City Univ Grad Sch Med Sci., 9.Dept. Hematol. Rheumatol., Tohoku Univ. Hosp., Sendai, 10.Center for Cancer Genomics and Advanced Therapeutics, National Cancer Center, 11.Human Genome Center, Inst. Med. Sci., Univ. Tokyo, Tokyo, 12.Dept. Pathol. Tumor Biol., Kyoto Univ., Kyoto)

Yoshiaki Usui1,3, Hidemi Ito1, Yuriko Koyanagi1, Tomohiro Matsuda2, Kota Katanoda2, Yoshinobu Maeda3, Keitaro Matsuo4 (1.Cancer Information and Control, Aichi Cancer Center, Aichi, Japan, 2.Cancer Control and Information Services, National Cancer Center, Tokyo, Japan, 3.Hematology, Oncology and Respiratory Medicine, Okayama University, Okayama, Japan, 4.Cancer Epidemiology and Prevention, Aichi Cancer Center, Aichi, Japan)

Ilseung Choi1, Nobuhiko Yamauchi2, Dai Maruyama3, Yoshiko Atsuta4, Rika Sakai5, Kazuho Miyashita6, Yukiyoshi Moriuchi7, Hideki Tsujimura8, Nobuko Kubota9, Go Yamamoto10, Tadahiko Igarashi11, Koji Izutsu3, Shinichiro Yoshida12, Kensuke Kojima13, Toshiki Uchida14, Yoshiko Inoue15, Norifumi Tsukamoto16, Eiichi Otsuka17, Sachiko Suzuki18, Yoko Inaguma19, Satoshi Ichikawa20, Hiroshi Gomyo21, Yoko Ushijima22, Kisato Nosaka23, Miho Kurata4, Yasuhito Tanaka24, Ryuzo Ueda25, Masashi Mizokami26, Shigeru Kusumoto27 (1.Department of Hematology, National Hospital Organization Kyushu Cancer Center, 2.Department of Hematology, National Cancer Center East Hospital, 3.Department of Hematology, National Cancer Center Hospital, 4.Japanese Data Center for Hematopoietic Cell Transplantation, 5.Department of Hematology and Medical Oncology, Kanagawa Cancer Center, 6.Department of Hematology, Yokohama City University Medical Center, 7.Department of Hematology, Sasebo City General Hospital, 8.Division of Hematology-Oncology, Chiba Cancer Center, 9.Department of Hematology, Saitama Cancer Center, 10.Department of Hematology, Toranomon Hospital, 11.Department of Hematology, Gunma Prefectural Cancer Center, 12.Department of Hematology, National Hospital Organization Nagasaki Medical Center, 13.Division of Hematology, Respiratory Medicine and Oncology, Saga University, 14.Department of Hematology-Oncology, Japanese Red Cross Nagoya Daini Hospital, 15.Department of Hematology, National Hospital Organization Kumamoto Medical Center, 16.Department of Hematology, Gunma University Hospital, Maebashi, 17.Department of Hematology, Oita prefectural Hospital, 18.Department of Hematology, National Hospital Organization Hokkaido Cancer Center, 19.Division of Hematology, Fujita Health University, 20.Hematology and Rheumatology, Tohoku University Graduate School of Medicine, 21.Division of Hematology, Hyogo Cancer Center, 22.Hematology and Oncology, Nagoya University Graduate School of Medicine, 23.Department of Hematology, Rheumatology and Infectious diseases, Kumamoto University Hospital, 24.Department of Virology and Liver unit, Nagoya City University, 25.Department of Tumor Immunology, Aichi Medical University School of Medicine, 26.Genome Medical Sciences, National Center for Global Health and Medicine, 27.Department of Hematology and Oncology, Nagoya City University Hospital)

Yuta Ito1, Akiko Maeshima2, Shunsuke Hatta1, Yo Saito1, Takahiro Fujino1, Shinichi Makita1, Suguru Fukuhara1, Wataru Munakata1, Hirokazu Taniguchi2, Tatsuya Suzuki1, Miyuki Sone3, Dai Maruyama1, Koji Izutsu1 (1.Department of Hematology, National Cancer Center Hospital, Tokyo, Japan, 2.Department of Pathology, National Cancer Center Hospital, Tokyo, Japan, 3.Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan)